| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Neurology (Drs. Meola and Sansone) and Institute of Neuroscience and Bioimaging National Research Council (Drs. Perani, Colleluori, and Fazio), H. San Raffaele, University of Milan, Italy; the Neurological Department, University of Brescia, and Instituto di Ricovero E Cura A Carattere Scientifico, S. Giovanni di Dio (Drs. Cappa and Cotelli), Brescia, Italy; and Department of Neurology (Drs. Thornton and Moxley), University of Rochester, NY.
Address correspondence and reprint requests to Dr. Giovanni Meola, Department of Neurology, University of Milan, San Donato Hospital, V. Morandi, 30, 20097–San Donato Milanese, Milan, Italy.
OBJECTIVE: To compare brain involvement in myotonic dystrophy (DM) with that of proximal myotonic myopathy (PROMM).
BACKGROUND: PROMM is a multisystem disease with many features in common with DM.
METHODS: Twenty patients with DM (CTG[500–700]), 20 patients with PROMM, and 20 normal control subjects were studied. Neuropsychological testing was performed in 12 patients with PROMM and in 18 patients with DM; brain MRI was performed in 17 of 20 PROMM patients and 15 of 20 DM patients. Ten patients with PROMM and 11 patients with DM were subjected to H215O PET.
RESULTS: Two-thirds of the patients with PROMM and one-half of those with DM were impaired on visual–spatial recall, whereas one-third of the patients with PROMM and less than half of those with DM showed an impairment in visual–spatial construction. Brain MRI was normal, or showed only nonspecific white matter abnormalities in both PROMM and DM patients. PET studies in PROMM patients showed a bilateral decrease in regional cerebral blood flow (rCBF) of the orbitofrontal and medial frontal cortex, whereas DM patients had more widespread hypoperfusion that extended to the dorsolateral frontal cortex and subcortical regions.
CONCLUSIONS: Impaired visual–spatial function may be present in proximal myotonic myopathy. This correlates best with a reduction in regional cerebral blood flow observed in H215O PET brain scans rather than with specific structural abnormalities observed on brain MRI.
Key words: Proximal myotonic myopathy—Myotonic dystrophy—PET—MRI—Neuropsychological tests.
This article has been cited by other articles:
|
|
 |
|
  C. Gagnon, L. Noreau, R. T Moxley, L. Laberge, S. Jean, L. Richer, M. Perron, S. Veillette, and J. Mathieu Towards an integrative approach to the management of myotonic dystrophy type 1 J. Neurol. Neurosurg. Psychiatry, August 1, 2007; 78(8): 800 - 806. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gaul, T. Schmidt, G. Windisch, T. Wieser, T. Muller, S. Vielhaber, S. Zierz, and B. Leplow Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2). Neurology, July 25, 2006; 67(2): 350 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. L. Ber, M. Martinez, D. Campion, A. Laquerriere, C. Betard, G. Bassez, C. Girard, P. Saugier-Veber, G. Raux, N. Sergeant, et al. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24 Brain, September 1, 2004; 127(9): 1979 - 1992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mankodi, C. R. Urbinati, Q.-P. Yuan, R. T Moxley, V. Sansone, M. Krym, D. Henderson, M. Schalling, M. S. Swanson, and C. A. Thornton Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2 Hum. Mol. Genet., September 1, 2001; 10(19): 2165 - 2170. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
